Across Asia Pacific, a quiet but consequential shift is underway in how pharmaceutical companies speak to the people they serve. Adeline Lim, Menarini's APAC CMO, has spent two years arguing that medicine's most persistent marketing failure is treating human beings as secondary to compounds — and building a practice that places empathy, cultural fluency, and creative courage alongside clinical evidence. Her work is a reminder that trust, not technology, remains the deepest currency in healthcare.